Sydbank A/S

  • ISIN: DK0010311471
  • Land: .

Nachricht vom 20.03.2017 | 09:25

Sydbank share buyback programme: transactions in week 11

Sydbank A/S / Miscellaneous

20-March-2017 / 09:25 CET/CEST
Dissemination of a Regulatory Announcement, transmitted by EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Aabenraa, Denmark, 2017-03-20 09:25 CET (GLOBE NEWSWIRE) --
On 1 March 2017 Sydbank announced a share buyback programme of DKK 664m. The
share buyback commenced on 2 March 2017 and will be completed by 31 December
2017.

The purpose of the share buyback programme is to reduce the share capital of
Sydbank and the programme is executed in compliance with the provisions of
Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16
April 2014 and the Commission Delegated Regulation (EU) 2016/1052 of 8 March
2016, collectively referred to as the Safe Harbour rules.

The following transactions have been made under the share buyback programme:

Number of VWAP Gross value (DKK)
shares
Accumulated, most 121,000 30,309,580.00
recent announcement
13 March 2017 15,000 14,000 253.78 252.80 3,806,700.00 3,539,200.00
14 March 2017 13,000 12,000 254.76 256.73 3,311,880.00
15 March 2017 11,000 256.91 3,080,760.00
16 March 2017 2,826,010.00
17 March 2017
Total over week 11 65,000 16,564,550.00
Total accumulated 186,000 46,874,130.00
during the share
buyback programme



All transactions were made under ISIN DK 0010311471 and effected by Danske Bank
A/S on behalf of Sydbank A/S.

Further information about the transactions, cf Article 5 of Regulation (EU) No
596/2014 of the European Parliament and of the Council on market abuse and the
Commission delegated regulation, is available in the attachment.

Following the above transactions, Sydbank holds a total of 2,892,309 own
shares, equal to 4.0% of the Bank's share capital.

Click on, or paste the following link into your web browser, to view
the associated documents

https://cns.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=620886


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de/ukreg



show this

GBC im Fokus

M1 Kliniken AG: Kursziel angehoben

Die M1 Kliniken AG hat den eingeschlagenen Wachstumskurs mit einem Umsatzanstieg von 20,3 % auch im ersten Halbjahr fortgesetzt. Analog dazu gelang es der Gesellschaft, einen überproportionalen Anstieg des EBIT um 36,5% zu erreichen und unsere Erwartungen zu übertreffen. Wir haben auf dieser Grundlage unsere Umsatz- und Ergebnisschätzungen angehoben. Bei einem Kursziel von 16,15 € ergibt sich ein hohes Kurspotenzial - damit lautet das Rating KAUFEN.

News im Fokus

ProSiebenSat.1 Media SE: Thomas Ebeling verlässt das Unternehmen Ende Februar 2018

19. November 2017, 19:10

Aktueller Webcast

ADO Properties S.A.

9M RESULTS 2017

15. November 2017

Aktuelle Research-Studie

MOLOGEN AG

Original-Research: Mologen AG (von First Berlin Equity Research GmbH): BUY

20. November 2017